The FDA recently approved a bioengineered blood vessel, which becomes part of a patient’s body over time. It’s designed to ...

DURHAM, N.C. - Humacyte, Inc. (NASDAQ:HUMA), a biotechnology firm specializing in bioengineered human tissues with a current market capitalization of $580 million, and Pluristyx, Inc., a provider of ...

Pluristyx has developed a clinical-grade manufacturing process for using a licensed Mad7 gene editing technology to block Human Leukocyte Antigen (HLA) markers expression. Humacyte is optimizing a ...

Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissue ...

DURHAM, N.C. - Humacyte, Inc. (NASDAQ:HUMA), a biotechnology company valued at $567 million, has announced its intention to file an Investigational New Drug (IND) application with the U.S. Food and ...

Plans for filing an IND was agreed with the FDA in a recent meeting –– Positive preclinical results of the small-diameter ATEV were recently ...

Laura Cowan and her children endure years of abuse while held captive in a cold and dark garage at the hands of the man who betrayed them. Search • Shop • Games • Calendar • Newsletters ...

Laura Caron, 34, of Cape May Court House, was arrested this week on charges of aggravated sexual assault and endangering the welfare of a child. PICTURED: Laura Caron appeared virtually before a ...

Cape May County prosecutors arrested fifth grade teacher Laura R. Caron, 34, Wednesday on charges including the aggravated assault of a minor living in her home. Caron gave birth in 2019 to a baby ...

Laura Caron, a fifth-grade teacher, is accused of sexually assaulting her ex-pupil when they lived together in her home between 2016 and 2020, the Cape May County Prosecutor’s Office revealed ...

The U.S. Food and Drug Administration (FDA) granted a full approval for Symvess on December 19, 2024 for use in adults as a vascular conduit for extremity arterial injury when ... for treating ...

The U.S. Food and Drug Administration (FDA) granted a full approval for Symvess on December 19, 2024 for use in adults as a vascular conduit ... injury,” said Laura Niklason, M.D., Ph.D ...